These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The cytokine and chemokine network in psoriasis. Nickoloff BJ; Xin H; Nestle FO; Qin JZ Clin Dermatol; 2007; 25(6):568-73. PubMed ID: 18021894 [TBL] [Abstract][Full Text] [Related]
3. Psoriasis: the epidermal component. Tschachler E Clin Dermatol; 2007; 25(6):589-95. PubMed ID: 18021897 [TBL] [Abstract][Full Text] [Related]
4. The role of the T cell in psoriasis and the action of cyclosporin in this disease. Fry L Acta Derm Venereol Suppl (Stockh); 1989; 146():133-4; discussion 134-5. PubMed ID: 2609854 [No Abstract] [Full Text] [Related]
6. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Albanesi C; De Pità O; Girolomoni G Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896 [TBL] [Abstract][Full Text] [Related]
7. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Sano S; Chan KS; Carbajal S; Clifford J; Peavey M; Kiguchi K; Itami S; Nickoloff BJ; DiGiovanni J Nat Med; 2005 Jan; 11(1):43-9. PubMed ID: 15592573 [TBL] [Abstract][Full Text] [Related]
8. [Immune system of the epidermis]. Démarchez M; Dallanegra A; Czernielewski J Ann Dermatol Venereol; 1991; 118(2):151-61. PubMed ID: 2048895 [No Abstract] [Full Text] [Related]
10. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation. Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319 [TBL] [Abstract][Full Text] [Related]
11. The presence of IFN-alpha immunostained cells in the psoriatic epidermis. McKenzie RC; Sabin E; Szepietowski JC; Em Howie S; Forsey RJ; Gracie JA Eur J Dermatol; 2003; 13(1):100-1. PubMed ID: 12609796 [No Abstract] [Full Text] [Related]
12. Immunoregulation in epidermis. II. Immunostimulatory and immunoinhibitory products of keratinocytes. Stosić-Grujicić S; Lukić ML Acta Derm Venereol Suppl (Stockh); 1989; 146():16-9. PubMed ID: 2609859 [No Abstract] [Full Text] [Related]
13. [The role of cytokines for the pathogenesis of psoriasis]. Kapp A Hautarzt; 1993 Apr; 44(4):201-7. PubMed ID: 8482597 [TBL] [Abstract][Full Text] [Related]
14. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Guttman-Yassky E; Krueger JG Br J Dermatol; 2007 Dec; 157(6):1103-15. PubMed ID: 17714560 [TBL] [Abstract][Full Text] [Related]
15. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis. Boniface K; Lecron JC; Bernard FX; Dagregorio G; Guillet G; Nau F; Morel F Eur Cytokine Netw; 2005 Dec; 16(4):309-19. PubMed ID: 16464746 [TBL] [Abstract][Full Text] [Related]
16. Psoriasis: dysregulation of innate immunity. Bos JD; de Rie MA; Teunissen MB; Piskin G Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970 [TBL] [Abstract][Full Text] [Related]
17. Chemokines and other mediators as therapeutic targets in psoriasis vulgaris. Homey B; Meller S Clin Dermatol; 2008; 26(5):539-45. PubMed ID: 18755373 [TBL] [Abstract][Full Text] [Related]
18. The immunologic and genetic basis of psoriasis. Nickoloff BJ Arch Dermatol; 1999 Sep; 135(9):1104-10. PubMed ID: 10490116 [No Abstract] [Full Text] [Related]
19. Three decades of psoriasis research: where has it led us? Sabat R; Sterry W; Philipp S; Wolk K Clin Dermatol; 2007; 25(6):504-9. PubMed ID: 18021885 [TBL] [Abstract][Full Text] [Related]
20. Psoriasis: genetic associations and immune system changes. Liu Y; Krueger JG; Bowcock AM Genes Immun; 2007 Jan; 8(1):1-12. PubMed ID: 17093502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]